Investment Thesis
Medical Properties Trust faces critical financial distress despite positive net income: negative operating cash flow of -$14.3M combined with $9.7B debt and interest coverage of 0.0x creates unsustainable leverage. The company cannot generate cash from operations to service debt obligations, indicating potential liquidity stress ahead.
Strengths
- Positive net income of $32.8M indicates some profitability despite operational headwinds
- Substantial asset base of $14.8B provides collateral and restructuring options
- EPS grew 88.6% YoY, suggesting earnings recovery from prior period lows
Risks
- Negative operating cash flow (-$14.3M) and negative free cash flow (-$14.3M) signal operational cash generation failure, critical for REIT viability
- Interest coverage ratio of 0.0x means operating income cannot cover debt service; company depends on non-operating income or asset sales
- High debt-to-equity ratio of 2.13x combined with negative cash flow creates severe refinancing and liquidity risk
- Revenue declining 2.4% YoY with extremely thin 0.1% operating margin indicates operational deterioration
- Return metrics critically weak: 0.7% ROE and 0.2% ROA demonstrate poor capital efficiency and value destruction
Key Metrics to Watch
- Operating cash flow trend - must turn positive to restore financial health and dividend sustainability
- Debt maturity schedule and refinancing ability given negative cash generation
- Revenue stabilization and operating margin expansion required to improve interest coverage
- Cash position depletion rate given negative FCF
Financial Metrics
Revenue
252.1M
Net Income
32.8M
EPS (Diluted)
$0.05
Free Cash Flow
-14.3M
Total Assets
14.8B
Cash
425.0M
Profitability Ratios
Gross Margin
N/A
Operating Margin
0.1%
Net Margin
13.0%
ROE
0.7%
ROA
0.2%
FCF Margin
-5.7%
Balance Sheet & Liquidity
Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
2.13x
Debt/Assets
69.2%
Interest Coverage
0.00x
Long-term Debt
9.7B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T07:47:29.693207 |
Data as of: 2026-03-31 |
Powered by Claude AI